SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-060294
Filing Date
2023-07-27
Accepted
2023-07-27 16:43:54
Documents
12
Period of Report
2023-07-26
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea182420-8k_inmunebio.htm   iXBRL 8-K 23776
  Complete submission text file 0001213900-23-060294.txt   197464

Data Files

Seq Description Document Type Size
2 XBRL LABEL FILE inmb-20230726_lab.xml EX-101.LAB 34240
3 XBRL PRESENTATION FILE inmb-20230726_pre.xml EX-101.PRE 22361
4 XBRL SCHEMA FILE inmb-20230726.xsd EX-101.SCH 3018
6 EXTRACTED XBRL INSTANCE DOCUMENT ea182420-8k_inmunebio_htm.xml XML 3414
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 231119123
SIC: 2836 Biological Products, (No Diagnostic Substances)